Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Tofocom 200 mg/300 mg Tablet
Manufacturer/Marketed By : Alkem Laboratories Ltd
$22.34 $17.42
Tofocom 200 mg/300 mg Tablet is a specialized antiretroviral therapy that combines the active ingredients emtricitabine and tenofovir disoproxil fumarate, designed for the treatment of Human Immunodeficiency Virus type 1...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Emtricitabine 200 mg + Tenofovir disoproxil fumarate 300 mg
Active Pharmaceutical Ingredient
Tofocom 200 mg/300 mg Tablet
$22.34
$17.42
Tofocom 200 mg/300 mg Tablet is a specialized antiretroviral therapy that combines the active ingredients emtricitabine and tenofovir disoproxil fumarate, designed for the treatment of Human Immunodeficiency Virus type 1 (HIV-1) in adults and adolescents aged 12 and older, provided they weigh at least 35 kg. This powerful medication works by inhibiting the replication of the virus, thereby helping to control HIV infection and significantly reduce the risk of progression to Acquired Immunodeficiency Syndrome (AIDS). It is crucial to adhere to prescribed dosages and consult healthcare professionals regularly, as improper use may lead to drug resistance. Patients should be aware of potential side effects and interactions with other medications, emphasizing the importance of comprehensive medical guidance during treatment. Tofocom not only aids in managing HIV effectively but also plays a vital role in enhancing the quality of life for those affected. By integrating this treatment into a holistic care plan, individuals can better navigate their health journey. Always prioritize regular follow-ups with your healthcare provider to ensure optimal outcomes with Tofocom.
Active Pharmaceutical Ingredient
Uses
• Tofocom 200 mg 300 mg tablet is primarily indicated for the treatment of human immunodeficiency virus (HIV) infection. This medication works by inhibiting the virus's ability to replicate, thereby helping to control the infection. Patients using Tofocom can experience improved immune function and a reduction in viral load. It is crucial for individuals diagnosed with HIV to adhere to their prescribed treatment regimen, including Tofocom.
• In addition to managing HIV, Tofocom 200 mg 300 mg tablet plays a significant role in the overall treatment strategy for individuals living with the virus. By effectively lowering the amount of HIV in the body, this medication helps reduce the risk of transmitting the virus to others. Healthcare providers often recommend Tofocom as part of a comprehensive approach that may include other antiretroviral therapies. Regular monitoring while on Tofocom ensures optimal therapeutic outcomes.
• Tofocom 200 mg 300 mg tablet is utilized in various healthcare settings to address the needs of patients with HIV. It is particularly beneficial for those who may have experienced treatment failures with other medications. The use of Tofocom can help restore the effectiveness of treatment plans and enhance the quality of life for patients. Patients should discuss their treatment options, including Tofocom, with their healthcare provider for tailored care.
• When prescribed, Tofocom 200 mg 300 mg tablet can be taken as part of a lifelong management plan for HIV. It is essential for patients to remain consistent with their dosage to achieve the best possible results. Tofocom not only aids in controlling the virus but also supports the immune system in fighting off infections. This dual benefit makes Tofocom a critical component in the ongoing care of individuals living with HIV.
Benefits
Tofocom Antiretroviral Drug is a combination of antiretroviral medicines that fights human immunodeficiency virus (HIV) infection by reducing the amount of the virus in the blood. It is used in antiretroviral combination therapy for the treatment of HIV infection. Tofocom HIV Medicine reduces the amount of HIV virus in your body and keeps it low. It also increases CD4 cell counts. CD4 cells are a type of white blood cell that plays an essential role in maintaining a healthy immune system to help fight infection. Response to treatment with Tofocom Antiretroviral Drug varies between patients. Your doctor or healthcare provider will be monitoring the effectiveness of your treatment. Tofocom 200 mg/300 mg Tablet may improve your condition, but it does not cure your HIV infection. HIV infection is a disease spread by contact with blood or sexual contact with an infected individual. Treatment with Tofocom Tablet has not been shown to eliminate the risk of passing HIV infection on to others by sexual contact or by blood transfer. Therefore, you must continue to take appropriate precautions to avoid giving the virus to others.
Side Effects
As with all medicines, Tofocom may cause side effects that do not require medical attention and that will disappear as your body adjusts to the medicine. If they persist or you're concerned about them, tell your doctor.
Most Common Side Effects
• Diarrhea
• Dizziness
• Fatigue
• Headache
• Nausea
• Rash
Common Side Effects
• Depression
• Anxiety
• Loss in appetite
• Stomach pain
• Blood in urine
• Changes in the amount of urine
How To Use
Tofocom can be taken with or without food. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Tofocom HIV Medicine. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking this medication.
• Kidney: Tofocom 200 mg/300 mg Tablet should be modified in HIV-infected adult patients with creatinine clearance of 30–49 mL/min. Tofocom Antiretroviral Drug should not be used in patients with creatinine clearance below 30 mL/min and in patients with end-stage renal disease requiring dialysis.
• Breastfeeding: Tofocom Antiretroviral Drug may pass into human milk. There is insufficient information on the effects of Tofocom HIV Medicine in newborns/infants. The use of Tofocom should not be used during breastfeeding.
• Liver: Tofocom 200/300 mg should be used with caution in patients with kidney disease. Dose adjustment of Tofocom 200/300 mg may be needed. Please consult your doctor.
• Pregnancy: Tofocom 200 mg/300 mg Tablet may be considered safe to use in pregnant women. There are no malformations or foetal/neonatal toxicity associated with Tofocom Tablet. Therefore the use of Tofocom Tablet may be considered during pregnancy, if necessary.
• Driving: Tofocom 200 mg/300 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Tofocom HIV Medicine.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.